Cited by 922Helicobacter pylori-related gastroenterology studiesGastrointestinal Bleeding Diagnosis and TreatmentHepatitis C virus research

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

Rauws, E.A.J., Tytgat, G.N.J.·1990·The Lancet

DOI 10.1016/0140-6736(90)91301-p

Open this paper in CoChat — free account

Abstract

50 patients with intractable duodenal ulcer were randomly assigned to 4 weeks of treatment with colloidal bismuth subcitrate (CBS) alone (26 patients) or with amoxicillin and metronidazole (24 patients). 5 patients (all on triple therapy) withdrew because of side-effects. In 17 of the 45 patients who completed the treatment, Helicobacter pylori was eradicated, and there was no ulcer relapse during the first 12 months of follow-up. The ulcer relapse rate was significantly higher (17 of 21 [89%]) among patients who remained positive for H pylori. 9 patients who remained positive for H pylori and had ulcer relapses within 6 months of treatment with CBS alone, were subsequently given triple therapy. 7 of the 9 showed H pylori eradication and no relapses within the next 12 months. The 2 patients still H pylori-positive after triple therapy had further ulcer relapses. H pylori eradication, without altering acid output, will become the mainstay of duodenal ulcer treatment because it cures the disease.

Integrity signals

Registry

Crossref · 10.1016/0140-6736(90)91301-p

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
Manual for the identification of medical bacteria.
Cowan, S. T., & Steel, K. (1965) · Cambridge University Press eBooks · Cited by 4,823
Attempt to fulfil Koch's postulates for pyloric Campylobacter
Marshall, B. J., Armstrong, J. A., McGechie, D. B., & Clancy, R. J. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb113443.x · Cited by 1,307
PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI
Marshall, B. J., Warren, J. R., Blincow, E., Phillips, M. R., Goodwin, C. S., Murray, R., Blackbourn, S., Waters, T. E., & Sanderson, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90929-4 · Cited by 1,035
Campylobacter pyloridis-associated chronic active antral gastritis
Rauws, E. A., Langenberg, W., Houthoff, H. J., Zanen, H. C., & Tytgat, G. N. J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90606-3 · Cited by 796
Self-citation
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.
Morris, A., & Nicholson, G. I. (1987) · PubMed · Cited by 750
CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY
Coghlan, G., Humphries, H., Dooley, C. P., Keane, C. T., Gilligan, D., Mckenna, D., Sweeney, E., & O'Morain, C. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91545-5 · Cited by 539
CAMPYLOBACTER-UKE ORGANISMS IN THE STOMACH OF PATIENTS AND HEALTHY INDIVIDUALS
Langenberg, M. L., Tytgat, G. N. J., Schipper, M. E. I., Rietra, P. J. G. M., Zanen, H. C., Burnett, R. A., Forrest, J. A. H., Girdwood, R. W. A., & Fricker, C. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91836-1 · Cited by 290
Self-citation
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
Jones, D. B., Howden, C. W., Burget, D. W., Kerr, G. D., & Hunt, R. H. (1987) · Gut · doi:10.1136/gut.28.9.1120 · Cited by 280
Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate
Martin, D., May, S., Tweedle, D. F., Hollanders, D., Ravenscroft, M., & Miller, J. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90114-8 · Cited by 262

Show all 23 references

Research works printed but not linked: 3

Lambert, 1987, Effect of colloiad bismuth (De-Nol) and healing relapse of duodenal ulcer-role of Campylobacter pyloridis., Gastroenterology, 92, 1489
Borody, 1988, Long term Campylobacter pylori recurrence post-eradication, Gastroenterology, 94, 43
Smith, 1988, A comparison of ranitidine and tripotassium dicitrato-bismuth (TDB) in relapse rate of duodenal ulcer. The role of Campylobacter pylori, Gastroenterology, 94, 431

Sorted by citations

Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
Peptic ulcer disease
Malfertheiner, P., Chan, F. K. L., & McColl, K. E. L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60938-7 · Cited by 1,558
Helicobacter pylori infection
Malfertheiner, P., Camargo, M. C., El-Omar, E. M., Liou, J., Peek, R. M., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,339
The Sydney System: Histological division
Price, A. B. (1991) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1991.tb01468.x · Cited by 991
Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal Ulcer: A Randomized, Controlled Study
Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Saeed, Z. A., & Malaty, H. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-705 · Cited by 909
Bleeding Peptic Ulcer
Laine, L., & Peterson, W. L. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409153311107 · Cited by 710
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
Hentschel, E., Brandstatter, G., Dragosics, B., Hirschl, A. M., Nemec, H., Schutze, K., Taufer, M., & Wurzer, H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280503 · Cited by 708
Helicobacter pylori and Peptic Ulcer Disease
Desforges, J. F., & Peterson, W. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104113241507 · Cited by 654
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology
Crabtree, J. E., Taylor, J. D., Heatley, R. V., Shallcross, T. M., Rathbone, B. J., Wyatt, J. I., & Tompkins, D. S. (1991) · The Lancet · doi:10.1016/0140-6736(91)90477-7 · Cited by 647
Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation
Blaser, M. J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90126-j · Cited by 606
The Disease Spectrum of Helicobacter Pylori: The Immunopathogenesis of Gastroduodenal Ulcer and Gastric Cancer
Ernst, P. B., & Gold, B. D. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.615 · Cited by 554
Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection
Cutler, A. F., Havstad, S. L., Chen, K., Blaser, M. J., Perez-Perez, G. I., & Schubert, T. T. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90278-3 · Cited by 529
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
El-Omar, E. M., Penman, I. D., Ardill, J. E. S., Chittajallu, R. S., Howie, C., & McColl, K. E. L. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90374-7 · Cited by 524
Mucosal Tumor Necrosis Factor-or, Interleukin-1/3, and Interleukin-8 Production in Patients with Helicobacter pylori Infection
Noach, L. A., Bosma, N. B., Jansen, J., Hoek, F. J., van Deventer, S. J. H., & Tytgat, G. N. J. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409096833 · Cited by 514
Self-citation
Symptomatic Benefit from EradicatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
McColl, K. E. L., Murray, L. S., El-Omar, E. M., Dickson, A., El-Nujumi, A., Wirz, A. A., Kelman, A. W., Penny, C., Knill-Jones, R. P., & Hilditch, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812243392601 · Cited by 500
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk.
Blaser, M. J., Chyou, P.-H., & Nomura, A. M. Y. (1995) · PubMed · Cited by 398
The Treatment ofHelicobacter pyloriInfection in the Management of Peptic Ulcer Disease
Walsh, J. H., & Peterson, W. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331508 · Cited by 376
Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS)
Beg, S., Ragunath, K., Wyman, A., Banks, M. R., Trudgill, N. J., Pritchard, D. M., Riley, S. A., Anderson, J., Griffiths, H. R., Bhandari, P., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-314109 · Cited by 367
A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates
Houben, van de Beek, D., Hensen, de Craen, A. J. M., Rauws, & Tytgat (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00555.x · Cited by 330
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology
Soll, A. H. (1996) · JAMA · doi:10.1001/jama.1996.03530320046033 · Cited by 329
A Randomized Study Comparing Laparoscopic Versus Open Repair of Perforated Peptic Ulcer Using Suture or Sutureless Technique
Lau, W. Y., Leung, K. L., Kwong, K., Davey, I. C., Robertson, C., Dawson, J. J. W., Chung, S. C. S., & LI, A. K. C. (1996) · Annals of Surgery · doi:10.1097/00000658-199608000-00004 · Cited by 305
Eradication therapy for peptic ulcer disease in Helicobacter pylori -positive people
Ford, A. C., Gurusamy, K. S., Delaney, B. C., Forman, D., & Moayyedi, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003840.pub5 · Cited by 290
Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease
Moran, A. P., Prendergast, M. M., & Appelmelk, B. J. (1996) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1996.tb00127.x · Cited by 288
Serologic detection of infection with cagA+ Helicobacter pylori strains
Cover, T. L., Glupczynski, Y., Lage, A. P., Burette, A. C., Tummuru, M. K. R., Perez-Perez, G. I., & Blaser, M. J. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.6.1496-1500.1995 · Cited by 287
Treatment of Helicobacter pylori Infection: A Review of the World Literature
van der Hulst, R. W. M., Keller, J. J., Rauws, E. A., & Tytgat, G. N. J. (1996) · Helicobacter · doi:10.1111/j.1523-5378.1996.tb00003.x · Cited by 284
Self-citation
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori
Iwahi, T., Satoh, H., Nakao, M., Iwasaki, T., Yamazaki, T., Kubo, K., Tamura, T., & Imada, A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.490 · Cited by 276
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial
HOSKING, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91460-5 · Cited by 262
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals
Ho, S., Hoyle, J. A., Lewis, F. A., Secker, A. D., Cross, D., Mapstone, N. P., Dixon, M. F., Wyatt, J. I., Tompkins, D. S., & Taylor, G. R. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.11.2543-2549.1991 · Cited by 261
Meta‐analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
TONG, J. L., Ran, Z. H., Shen, J., Zhang, C.-J., & Xiao, S. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03179.x · Cited by 256
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.
El-Omar, E. M., Penman, I. D., Dorrian, C. A., Ardill, J. E. S., & MCCOLL, K. E. L. (1993) · Gut · doi:10.1136/gut.34.8.1060 · Cited by 255
Treatment of Helicobacter pylori Reduces the Rate of Rebleeding in Peptic Ulcer Disease
Graham, D. Y., Hepps, K. S., Ramirez, F. C., Lew, G. M., & Saeed, Z. A. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098288 · Cited by 251
Trends in Perforated Peptic Ulcer: Incidence, Etiology, Treatment, and Prognosis
Svanes, C. (2000) · World Journal of Surgery · doi:10.1007/s002689910045 · Cited by 236
Seroconversion for Helicobacter pylori
Kuipers, E. J., Peña, A. S., Pels, N. F. M., Kurz-Pohlmann, E., Meuwissen, S. G. M., van Kamp, G. J., Uyterlinde, A. M., & Pals, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91473-y · Cited by 229
Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease
Rokkas, T., Karameris, A., Mavrogeorgis, A., Rallis, E. A., & Giannikos, N. (1995) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(95)70266-0 · Cited by 227
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial
Graham, D. Y., Lew, G. M., Evans, D. G., Evans, D. J., & Klein, P. D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-4-266 · Cited by 222
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum.
Craanen, M. E., Dekker, W., Blok, P., Ferwerda, J., & Tytgat, G. N. J. (1992) · Gut · doi:10.1136/gut.33.1.16 · Cited by 216
Self-citation
Screening dyspepsia by serology to Helicobacter pylori
Sobala, G. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90085-4 · Cited by 216
Susceptibility of Helicobacter Pylori to the Antibacterial Activity of Manuka Honey
Somal, N. A., Coley, K., Molan, P. C., & Hancock, B. M. (1994) · Journal of the Royal Society of Medicine · doi:10.1177/014107689408700106 · Cited by 214
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers
Bayerdörffer, E., Miehlke, S., Mannes, G. A., Sommer, A., Höchter, W., Weingart, J., Heldwein, W., Klann, H., Simon, T. J., Schmitt, W., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90689-4 · Cited by 210
Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
van Zanten, S. J. V., & Sherman, P. M. (1994) · Europe PMC (PubMed Central) · Cited by 208
Proton Pump Inhibitors and Acid‐Related Diseases
Sachs, G. M. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03675.x · Cited by 207
Pantoprazole
Fitton, A., & Wiseman, L. R. (1996) · Drugs · doi:10.2165/00003495-199651030-00012 · Cited by 206
Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori
Malekzadeh, F., Ehsanifar, H., Shahamat, M., Levin, M. A., & Colwell, R. R. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00352-1 · Cited by 204
Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection
Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., & Walker, R. I. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.3581-3590.2001 · Cited by 201
Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin--Influence on Treatment Outcome
Adamek, R. J., Suerbaum, S., Pfaffenbach, B., & Opferkuch, W. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00110-x · Cited by 200
The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections
McMahon, B. J., Hennessy, T. W., Bensler, J. M., Bruden, D. L., Parkinson, A. J., Morris, J. M., Reasonover, A. L., Hurlburt, D. A., Bruce, M. G., Sacco, F. D., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00008 · Cited by 197
Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage
Jaspersen, D. J., Körner, T., Schorr, W., Brennenstuhl, M., Raschka, C. J., & Hammar, C. (1995) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(95)70267-9 · Cited by 188
Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistance
Bell, G. D., Powell, K. U., BURRIDGE, S. M., Pallecaros, A., Jones, P. H., GANT, P. W., Harrison, G. A. J., & TROWELL, J. E. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00556.x · Cited by 180
Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides
Moran, A. P., Helander, I. M., & Kosunen, T. U. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.4.1370-1377.1992 · Cited by 179
Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis
Ford, A. C., Delaney, B. C., Forman, D., & Moayyedi, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40014.x · Cited by 173
Eradication of Helicobacter pylori with clarithromycin and omeprazole.
Logan, R., Gummett, P. A., Schaufelberger, H., Greaves, R., Mendelson, G. M., Walker, M. M., Thomas, P. H., Baron, J. H., & Misiewicz, J. J. (1994) · Gut · doi:10.1136/gut.35.3.323 · Cited by 173
Helicobacter pylori: perspectives and time trends
Malfertheiner, P., Link, A., & Selgrad, M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.99 · Cited by 172
Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence
Tytgat, G. N. J. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00303.x · Cited by 172
Self-citation
Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.
Labenz, J., & Börsch, G. (1994) · Gut · doi:10.1136/gut.35.1.19 · Cited by 167
Helicobacter pylori: present status and future prospects in Japan
Suzuki, H., Hibi∥, T., & Marshall, B. J. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1990-z · Cited by 162
Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection.
Reinbach, D., Cruickshank, G., & McColl, K. E. L. (1993) · Gut · doi:10.1136/gut.34.10.1344 · Cited by 160
Lansoprazole
Barradell, L. B., Faulds, D. M., & McTavish, D. (1992) · Drugs · doi:10.2165/00003495-199244020-00007 · Cited by 159
Changing Antimicrobial Susceptibility Epidemiology of Helicobacter pylori Strains in Japan between 2002 and 2005
Kobayashi, I., Murakami, K., Kato, M., Kato, S., Azuma, T., Takahashi, S., Uemura, N., Katsuyama, T., Fukuda, Y., Haruma, K., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00740-07 · Cited by 156
Antrum- and Corpus Mucosa-Infiltrating CD4+Lymphocytes inHelicobacter pyloriGastritis Display a Th1 Phenotype
Sommer, F. O., Faller, G., Konturek, P. C., Kirchner, T., Hahn, E. G., Zeus, J., Röllinghoff, M., & Lohoff, M. D. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5543-5546.1998 · Cited by 155
A newly developed PCR assay ofH. pylori in gastric biopsy, saliva, and feces
Li, C., Ha, T., Ferguson, D. A., Chi, D. S., Zhao, R., Patel, N. R., Krishnaswamy, G. A., & Thomas, E. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02071393 · Cited by 154
Helicobacter pylori and duodenal ulcer
graud, F. M., & LAMOULIATTE, H. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01296437 · Cited by 154
The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori
Take, S., Mizuno, M., Ishiki, K., Yoshida, T., Ohara, N., Yokota, K., Oguma, K., Okada, H., & Yamamoto, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0347-9 · Cited by 153
Role of metronidazole resistance in therapy of Helicobacter pylori infections
Rautelin, H. I. K., Seppälä, K., Renkonen, O. V., Vainio, U., & Kosunen, T. U. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.163 · Cited by 151
Cinnamon extracts’ inhibitory effect on Helicobacter pylori
Tabak, M., Armon, R. H., & Neéman, I. (1999) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00054-9 · Cited by 150
Lansoprazole
Spencer, C. M., & Faulds, D. M. (1994) · Drugs · doi:10.2165/00003495-199448030-00007 · Cited by 149
Endoscopic therapy of acute diverticular hemorrhage
Bloomfeld, R. S., Rockey, D. C., & Shetzline, M. A. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02611-9 · Cited by 146
A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration.
McColl, K. E. L., El-Nujumi, A., Chittajallu, R. S., Dahill, S., Dorrian, C. A., El-Omar, E. M., Penman, I. D., Fitzsimons, E. J., Drain, J., & Graham, H. (1993) · Gut · doi:10.1136/gut.34.6.762 · Cited by 145
Disappearance of Gastritis after Eradication ofHelicobacter pylori: A Morphometric Study
Valle, J., Seppälä, K., Sipponen, P., & Kosunen, T. U. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529109003956 · Cited by 143
One week eradication regimen for Helicobacter pylori
Logan, R. P., Gummett, P. A., Misiewicz, J. J., Karim, Q. N., Walker, M. M., & Baron, J. H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92111-e · Cited by 142
Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying
Perri, F., Clemente, R., Festa, V., Annese, V., Quitadamo, M., Rutgeerts, P. J., & Andriulli, A. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00597.x · Cited by 141
The Recurrence of Helicobacter pylori Infection: Incidence and Variables Influencing It. A Critical Review
Gisbert, J. P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50043.x · Cited by 138
Results of a multicentre European survey in 1991 of metronidazole resistance inHelicobacter pylori
European Study Group on Antibiotic Susceptibility of Helicobacter pylori (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01960875 · Cited by 138
Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation.
Fan, X. J., Chua, A., Shahi, C. N., McDevitt, J., Keeling, P. W. N., & Kelleher, D. P. (1994) · Gut · doi:10.1136/gut.35.10.1379 · Cited by 136
HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE
Tytgat, G. N. J., Noach, L. A., & Rauws, E. A. (1993) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00268-5 · Cited by 136
Self-citation
Helicobacter pylori and peptic ulcers: the present position.
Moss, S. F., & Calam, J. (1992) · Gut · doi:10.1136/gut.33.3.289 · Cited by 136
Gastric cancer among American Indians and Alaska Natives in the United States, 1999-2004
Wiggins, C. L., Perdue, D. G., Henderson, J. A., Bruce, M. G., Lanier, A. P., Kelley, J. J., Seals, B. F., & Espey, D. K. (2008) · Cancer · doi:10.1002/cncr.23732 · Cited by 134
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients
Ford, A. C., Delaney, B. C., Forman, D., & Moayyedi, P. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003840.pub4 · Cited by 134
The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection
de Vries, A. C., Haringsma, J., & Kuipers, E. J. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00475.x · Cited by 132
Omeprazole plus Amoxicillin for Cure of Helicobacter pylori Infection Factors Influencing the Treatment Success
Labenz, J., Leverkus, F., & Börsch, G. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409094890 · Cited by 131
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Labenz, J., Gyenes, E., Rühl, G. H., & Börsch, G. (1993) · Gut · doi:10.1136/gut.34.9.1167 · Cited by 130
Review article: Helicobacter pylori eradication–understandable caution but no excuse for inertia
Penston, J. G. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00304.x · Cited by 129
Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
Ford, A. C., Malfertheiner, P., Giguère, M., Santana, J. O., Khan, M., & Moayyedi, P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.7361 · Cited by 127
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.
Moshkowitz, M., Konikoff, F. M., Peled, Y., Santo, M., Hallak, A., Bujanover, Y., Tiomny, E., & Gilat, T. (1995) · Gut · doi:10.1136/gut.36.6.845 · Cited by 126
Pharmacological aspects of acid secretion
Hirschowitz, B. I., Keeling, D., Lewin, M., Okabe, S., Parsons, M., Sewing, K.-F., Wallmark, B., & Sachs, G. M. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02214869 · Cited by 125
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection
Wong, W. M., Gu, Q., Lam, S. K., Fung, F. M. Y., Lai, K. C., Hu, W., Yee, Y. K., Chan, C. K., Xia, H. H., Yuen, M., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01459.x · Cited by 124
Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate:flavodoxin oxidoreductase from Helicobacter pylori
Hughes, N. J., Chalk, P. A., Clayton, C. L., & Kelly, D. J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.3953-3959.1995 · Cited by 122
The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model
Roderick, P. J., Davies, R. J., Raftery, J., Crabbe, D., Pearce, R., Bhandari, P., & Patel, P. (2003) · Health Technology Assessment · doi:10.3310/hta7060 · Cited by 121
Treatment options for Helicobacter pylori infection when proton pump inhibitor‐based triple therapy fails in clinical practice
LEE, Breslin, HYDE, BUCKLEY, & O’morain (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00504.x · Cited by 118
Dental Plaque: A Permanent Reservoir ofHelicobacter pylori?
Desai, H. G., Gill, H. H., Shankaran, K., Mehta, P. R., & Prabhu, S. R. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529108998615 · Cited by 117
The Very Model of a Modern Etiology: A Biopsychosocial View of Peptic Ulcer
Levenstein, S. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200003000-00003 · Cited by 117
Real-Time Quantitative PCR for Detection ofHelicobacter pylori
He, Q., Wang, J., Osato, M. S., & Lachman, L. B. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3720-3728.2002 · Cited by 117
Helicobacter pylori infection in perforated peptic ulcer disease
Sebastián, M., Chandran, V. P. P., Elashaal, Y., & Sim, A. J. W. (1995) · British journal of surgery · doi:10.1002/bjs.1800820325 · Cited by 117
Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer
Hosking, S. W., Ling, T. K., Yung, M. Y., Cheng, A., Chung, S. C., Leung, J. W., & Li, A. K. (1992) · BMJ · doi:10.1136/bmj.305.6852.502 · Cited by 117
Cholesterol Enhances Helicobacter pylori Resistance to Antibiotics and LL-37
McGee, D. J., George, A. E., Trainor, E. A., Horton, K. E., Hildebrandt, E. F., & Testerman, T. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00016-11 · Cited by 116
Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects.
Khulusi, S., Mendall, M. A., Patel, P., Levy, J., Badve, S., & Northfield, T. C. (1995) · Gut · doi:10.1136/gut.37.3.319 · Cited by 116
Relationship of Helicobacterpylori CagA Status to Gastric Cell Proliferation and Apoptosis
Rokkas, T., Ladas, S., Liatsos, C., Petridou, E., Papatheodorou, G., Theocharis, S., Karameris, A., & Raptis, S. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026636803101 · Cited by 116
Amoxycillin tolerance in Helicobacter pylori
Dore, M. P., Osato, M. S., Realdi, G., Mura, I., Graham, D. Y., & Sepulveda, A. R. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.47 · Cited by 113
The Relationship of ABO Blood Group, Age, Gender, Smoking, and Helicobacter pylori Infection
Kanbay, M., Gür, G., Arslan, H., Yılmaz, U., & Boyacıoğlu, S. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2762-y · Cited by 112
High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease.
Banatvala, N., Davies, G. R., Abdi, Y., Clements, L., Rampton, D. S., Hardie, J. M., & Feldman, R. A. (1994) · Gut · doi:10.1136/gut.35.11.1562 · Cited by 112

Authors: Rauws, E. A. J., & Tytgat, G. N. J.
Affiliations: Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author: Rauws, E.A.J.
Venue: The Lancet
Publisher: Elsevier BV
Published: 1990-05
Volume: 335
Issue: 8700
Pages: 1233-1235
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/0140-6736(90)91301-p
OpenAlex: W2029865847
Cited by: 922
References: 23
Citations by year: 2026: 2 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 12 · 2016: 13 · 2015: 10 · 2014: 18 · 2013: 11 · 2012: 14
FWCI: 106.47
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Keywords: duodenal ulcer, Helicobacter pylori eradication, bismuth subcitrate, amoxicillin, metronidazole, triple therapy, ulcer recurrence
MeSH terms: Administration, Oral, Amoxicillin, Anti-Ulcer Agents, Campylobacter, Campylobacter Infections, Drug Administration Schedule, Drug Evaluation, Drug Therapy, Combination, Duodenal Ulcer, Follow-Up Studies, Gastric Mucosa, Humans, Metronidazole, Organometallic Compounds, Prospective Studies, Recurrence, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks